Khaled Salman

Khaled Salman

Auto-generated profile, based on publicly available information

Khaled Salman

Research Center, King Abdullah Medical City, Makkah Healthcare Cluster

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Journal of Hospital Infection
Verified
Journal Article
Closed access
HHHassan Haridi
Hassan Haridi
KSK.A. Salman
K.A. Salman
EBE.A. Basaif
E.A. Basaif
DAD.K. Al-Skaibi
D.K. Al-Skaibi

1 January 2020 in Indian Journal of Nuclear Medicine
Verified
Journal Article
Open access
SWShereen Wagieh
Shereen Wagieh
KSKhaled Salman
Khaled Salman
ABAquib Bakhsh
Aquib Bakhsh
OTOmnia Talaat
Omnia Talaat
SMSoha Al Morsy
Soha Al Morsy
NANasser Al-Juhani
Nasser Al-Juhani
D incidence of higher activity of either thyroid lobe in patients with GD through analysis of quantitative data of Tc-99m thyroid scan and possible relation of different thyroid lobar activity to gender, age, and total thyroid uptake (TTU) level. Materials and Methods: Retrospective analysis of quantitative data of Tc-99m thyroid scan in patients with GD was done. Total and lobar thyroid uptake levels were analyzed and correlated with age, gender, and TTU. Results: GD was reported in 222 patients, representing 76.6% of those with hyperthyroidism, women represent 70.3% of patients. The right thyroid lobe uptake (RLU) figures were significantly higher compared to the left in the whole group as well as in women and in young patients (30% had higher RLU figures. Conclusion: There is significant preferential thyroid lobar affection in favor of the right thyroid lobe in patients with GD, with significantly higher RLU figures and significantly more incidence of patients with higher right lobar activity. This significance is maintained in women and in young patients and lost in men and old patients. The incidence of higher right thyroid lobe activity also increases in association with increase in TTU. Our results emphasize the value of Tc99m thyroid scan in patients with GD, especially when surgery is the treatment of choice, helping to tailor suitable surgical procedure for each individual patient....

9 September 2018 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
JIJoseph Ingrassia
Joseph Ingrassia
YYYoung Jin Youn
Young Jin Youn
JLJuyong Lee
Juyong Lee
MAMichael Azrin
Michael Azrin
SKSalman Khalid
Salman Khalid

9 January 2020 in Journal of the Egyptian National Cancer Institute
Verified
Journal Article
Open access
PDF file
KSKhaled Salman
Khaled Salman
SWShereen Wagieh
Shereen Wagieh
ABAquib Bakhsh
Aquib Bakhsh
TATarek Al-Monshy
Tarek Al-Monshy
OTOmnia Talaat
Omnia Talaat
GHGihad Hamid
Gihad Hamid
Background: Radiation exposure from patients treated with radioactive iodine (131I) represents a radiation hazard to children and adolescents, representing the most vulnerable group of household contacts. Our aim was to calculate the cumulative radiation exposure (CRE) figures to children and adolescents sharing the same home with outpatients treated with low-dose 131I. The secondary aim was to study the demographic and educational factors that may significantly affect radiation exposure to them. Results: The whole number of household contacts less than 18 years was 99, out of them 49 ≤ 12 years. CRE level to children and adolescents ranged from 79 to 934 uSv. The mean, median, and 75th percentile figures were 284 ± 178 uSv, 215 uSv, and 334 uSv, respectively. The compliance of this group of contacts to radiation exposure constraint (1 mSv) was 100%. All CRE values were below this figure with 75% of them below half of this constraint. Thirteen adolescents from 12 to 18 years and 17 mothers of 23 household contacts ≤ 12 years got radiation safety instructions (RSI) directly from a radiation safety officer (RSO). This group had a significantly lower mean CRE value (184 ± 93 uSv) compared to those who got RSI from the patient or from other family members (298 ± 185 uSv) with a significant p value. Conclusion: The compliance of adolescents and children to the 1-mSv radiation exposure constraint is 100%. It is advised for adolescents and mothers of children in contact with 131I-treated patients to get direct RSI from the RSO, which is the only factor associated with significantly lower radiation exposure figures.

1 December 2018 in Egyptian Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
KSK.H. Salman
K.H. Salman
SWSh. Wagih
Sh. Wagih
TMT. Munshi
T. Munshi
MAM. Almalki
M. Almalki
SZS. Zatari
S. Zatari
MAM. Al-Ezzi
M. Al-Ezzi

1 February 2015 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
SESherif M. El-Refaei
Sherif M. El-Refaei
SYShereen W. Yassin
Shereen W. Yassin
KSKhaled Salman
Khaled Salman
TMTarek Al Munshy
Tarek Al Munshy
MAManal Al-Ezzi
Manal Al-Ezzi
MHMaha Abd Elkareem Husseni
Maha Abd Elkareem Husseni
The aim of this study was to assess ablation outcome after a second ablation dose and compare the ablation rate after low and high reablation doses of iodine-131 ((131)I) after failure of the first ablation with 3700 MBq.The study included 81 patients with papillary thyroid cancer; they failed to achieve complete ablation after a first ablative dose of 3700 MBq. Their first follow-up (131)I whole-body scan carried out 6-9 months after ablation showed small residual functioning tissue in the thyroid bed, with no functioning metastases. This is associated with unsuppressed serum thyroglobulin level (Tg) higher than 2 ng/ml. The patients received a second ablation dose, which was low (1110 MBq) in 37 patients and high in the remaining 44 patients (2960 MBq in 36 patients and 3700 MBq in eight patients). A whole-body scan and Tg level assessment were carried out 6-9 months later. The criteria for complete ablation included absence of residual functioning thyroid tissue and a Tg level lower than 2 ng/ml.The overall successful complete ablation rate after the second reablation dose was 75%. This was achieved in 27 of 37 patients (73%) who received a low reablation dose and in 34 of 44 patients (77%) who received a high reablation dose; no statistically significant difference was found between the two groups (P>0.05).In patients with papillary thyroid cancer who failed to achieve complete ablation after the first ablation dose of 3700 MBq, the overall complete ablation rate after both a low and a high second (131)I dose was 75%, with no statistically significant difference in ablation rate between low (1110 MBq) and high (2960 and 3700 MBq) doses (73 and 77%, respectively).